EyePoint, Inc. (EYPT) Operating Margin
- Operating margin · 12 months: Value -11369.30%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -11369.30% | Operating income / revenue. Period ending 2026-06-30. $-316.98M ÷ $2.79M × 100 ≈ -11369.30% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -316.98M USD | Operating Income (Loss) |
| Revenue | 2.79M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | 262.72M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-316.98M | $2.79M | (m) | $262.72M | (m) | -11369.30% |
| 2026-03-31 | $-281.82M | $7.61M | (m) | $234.61M | (m) | -3701.38% |
| 2025-12-31 | $-243.43M | $31.37M | (m) | $221.04M | (m) | -775.98% |
| 2025-09-30 | $-218.33M | $42.34M | (m) | $205.20M | (m) | -515.67% |
| 2025-06-30 | $-189.05M | $51.90M | (m) | $186.99M | (m) | -364.27% |
| 2025-03-31 | $-161.37M | $56.04M | (m) | $161.36M | (m) | -287.94% |
| 2024-12-31 | $-145.85M | $43.27M | (m) | $132.93M | (m) | -337.06% |
| 2024-09-30 | $-116.97M | $45.71M | (m) | $107.50M | (m) | -255.88% |
| 2024-06-30 | $-98.62M | $50.39M | (m) | $95.33M | (m) | -195.71% |
| 2024-03-31 | $-86.83M | $50.02M | (m) | $81.18M | (m) | -173.60% |
| 2023-12-31 | $-75.07M | $46.02M | (m) | $64.66M | (m) | -163.13% |
| 2023-09-30 | $-102.45M | $42.52M | (m) | $62.25M | (m) | -240.92% |
| 2023-06-30 | $-106.45M | $37.33M | (m) | $56.05M | (m) | -285.14% |
| 2023-03-31 | $-102.91M | $39.79M | (m) | $53.31M | (m) | -258.61% |
| 2022-12-31 | $-99.64M | $41.40M | (m) | $49.64M | (m) | -240.65% |
| 2022-09-30 | $-73.95M | $42.41M | (m) | $43.02M | (m) | -174.35% |
| 2022-06-30 | $-70.86M | $41.46M | (m) | $40.35M | (m) | -170.91% |
| 2022-03-31 | $-62.63M | $38.91M | (m) | $32.97M | (m) | -160.95% |
| 2021-12-31 | $-55.28M | $36.94M | (m) | $28.50M | (m) | -149.64% |
| 2021-09-30 | $-49.96M | $32.53M | (m) | $24.79M | (m) | -153.61% |
| 2021-06-30 | $-36.61M | $39.16M | (m) | $20.38M | (m) | -93.48% |
| 2021-03-31 | $-36.78M | $34.27M | (m) | $18.05M | (m) | -107.32% |
| 2020-12-31 | $-37.29M | $34.44M | (m) | $17.42M | (m) | -108.28% |
| 2020-09-30 | $-33.54M | $35.94M | (m) | $16.35M | (m) | -93.32% |
| 2020-06-30 | $-45.64M | $22.75M | (m) | $15.74M | (m) | -200.58% |
| 2020-03-31 | $-44.65M | $25.84M | (m) | $16.42M | (m) | -172.80% |
| 2019-12-31 | $-47.86M | $20.36M | (m) | $15.37M | (m) | -235.02% |
| 2019-09-30 | $-49.88M | $14.17M | (m) | $15.41M | (m) | -351.94% |
| 2019-06-30 | $-49.38M | $12.15M | (m) | $18.16M | (m) | -406.38% |
| 2019-03-31 | $-48.99M | $5.66M | (m) | (m) | (m) | -866.35% |
| 2018-12-31 | $-39.02M | $4.57M | (m) | $18.50M | (m) | -853.62% |
| 2018-09-30 | $-33.82M | $3.06M | (m) | $18.59M | (m) | -1104.57% |
| 2018-06-30 | $-26.27M | $2.96M | (m) | $16.18M | (m) | -887.34% |
| 2018-03-31 | $-22.63M | $2.95M | (m) | $15.63M | (m) | -767.83% |
| 2017-12-31 | $-23.11M | $2.61M | (m) | $15.63M | (m) | -885.78% |
| 2017-09-30 | $-17.40M | $7.65M | (m) | $14.52M | (m) | -227.49% |
| 2017-06-30 | $-18.58M | $7.54M | (m) | $14.88M | (m) | -246.40% |
| 2017-03-31 | $-18.90M | $7.14M | (m) | $14.77M | (m) | -264.58% |
| 2016-12-31 | $-18.83M | $6.88M | (m) | $14.52M | (m) | -273.88% |
| 2016-09-30 | $-23.98M | $1.43M | (m) | $15.08M | (m) | -1675.47% |
| 2016-06-30 | $-21.77M | $1.62M | (m) | $14.38M | (m) | -1344.07% |
| 2016-03-31 | $-20.52M | $1.73M | (m) | $13.47M | (m) | -1189.45% |
| 2015-12-31 | $-20.47M | $1.73M | (m) | $13.74M | (m) | -1184.15% |
| 2015-09-30 | $-19.35M | $1.72M | (m) | $12.79M | (m) | -1122.51% |
| 2015-06-30 | $6.42M | $26.57M | (m) | $12.09M | (m) | 24.17% |
| 2015-03-31 | $7.61M | $26.45M | (m) | $11.20M | (m) | 28.77% |
| 2014-12-31 | $10.44M | $28.11M | (m) | $10.13M | (m) | 37.14% |
| 2014-09-30 | $11.02M | $28.18M | (m) | $9.85M | (m) | 39.09% |
| 2014-06-30 | $-13.49M | $3.47M | (m) | $9.57M | (m) | -388.42% |
| 2014-03-31 | $-13.46M | $3.67M | (m) | $9.59M | (m) | -366.43% |
| 2013-12-31 | $-14.05M | $2.19M | (m) | $8.90M | (m) | -640.47% |
| 2013-09-30 | $-13.16M | $2.19M | (m) | $7.99M | (m) | -601.69% |
| 2013-06-30 | $-12.03M | $2.14M | (m) | $7.00M | (m) | -561.41% |
| 2013-03-31 | $-10.36M | $2.35M | (m) | $6.09M | (m) | -440.85% |
| 2012-12-31 | $-10.28M | $2.38M | (m) | $6.02M | (m) | -432.63% |
| 2012-09-30 | $-25.27M | $2.42M | (m) | $6.43M | (m) | -1044.21% |
| 2012-06-30 | $-25.21M | $3.53M | (m) | $7.04M | (m) | -715.00% |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $-10.00M | $4.96M | (m) | $6.86M | (m) | -201.47% |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | $9.09M | $23.05M | (m) | $6.99M | (m) | 39.44% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |